Evidence map›Paper›PMID 39259521›Full record

Trial reportHealth technology assessment (Winchester, England)2024

The UK resuscitative endovascular balloon occlusion of the aorta in trauma patients with life-threatening torso haemorrhage: the (UK-REBOA) multicentre RCT.

Jan O Jansen, Jemma Hudson, Charlotte Kennedy, Claire Cochran, Graeme MacLennan, Katie Gillies, Robbie Lendrum, Samy Sadek, Dwayne Boyers, Gillian Ferry and 16 more

Abstract readMulticenter StudyPragmatic Clinical TrialRandomized Controlled Trial
In one paragraph

Trial report in Health technology assessment (Winchester, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors.

Jan O JansenHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0001-8863-4398
Jemma HudsonHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-6440-6419
Charlotte KennedyHealth Economics Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-1974-6318
Claire CochranHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0001-7349-7685
Graeme MacLennanHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-1039-5646
Katie GilliesHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0001-7890-2854
Robbie LendrumRoyal London Hospital, London, UK.ORCID 0000-0003-3206-3228
Samy SadekRoyal London Hospital, London, UK.ORCID 0009-0009-6064-1102
Dwayne BoyersHealth Economics Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-9786-8118
Gillian FerryHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0009-0006-9012-9271
Louisa LawrieHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-9867-2184
Mintu NathMedical Statistics Team, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-0753-0464
Seonaidh CottonHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-7883-0608
Samantha WilemanHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-1031-1449
Mark ForrestHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0002-2395-8823
Karim BrohiBlizard Institute, Queen Mary University of London, London, UK.ORCID 0000-0003-0643-8866
Tim HarrisRoyal London Hospital, London, UK.ORCID 0000-0002-9146-258X
Fiona LeckySchool of Health and Related Research, University of Sheffield, Sheffield, UK.ORCID 0000-0001-6806-0921
Chris MoranQueens Medical Centre, Nottingham, UK.ORCID 0009-0006-8886-8884
Jonathan J MorrisonMayo Clinic College of Medicine and Science, Rochester, MN, USA.ORCID 0000-0001-7462-8456
John NorrieUniversity of Edinburgh, Edinburgh, UK.ORCID 0000-0001-9823-9252
Alan PatersonLaw School, University of Strathclyde, Glasgow, UK.ORCID 0000-0001-5885-0743
Nigel TaiBarts Health NHS Trust, London, UK.ORCID 0000-0001-8493-9063
Nick WelchPatient and Public Involvement Representative, London, UK.ORCID 0000-0003-4201-9781
Marion K CampbellHealth Services Research Unit, University of Aberdeen, Aberdeen, UK.ORCID 0000-0001-5386-4097
UK-REBOA Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The most common cause of preventable death after injury is haemorrhage. Resuscitative endovascular balloon occlusion of the aorta is intended to provide earlier, temporary haemorrhage control, to facilitate transfer to an operating theatre or interventional radiology suite for definitive haemostasis. Objective: To compare standard care plus resuscitative endovascular balloon occlusion of the aorta versus standard care in patients with exsanguinating haemorrhage in the emergency department. Design: Pragmatic, multicentre, Bayesian, group-sequential, registry-enabled, open-label, parallel-group randomised controlled trial to determine the clinical and cost-effectiveness of standard care plus resuscitative endovascular balloon occlusion of the aorta, compared to standard care alone. Setting: United Kingdom Major Trauma Centres. Participants: Trauma patients aged 16 years or older with confirmed or suspected life-threatening torso haemorrhage deemed amenable to adjunctive treatment with resuscitative endovascular balloon occlusion of the aorta. Interventions: Participants were randomly assigned 1 : 1 to: standard care, as expected in a major trauma centre standard care plus resuscitative endovascular balloon occlusion of the aorta. Main outcome measures: Data sources: Case report forms, Trauma Audit and Research Network registry, NHS Digital (Hospital Episode Statistics and Office of National Statistics data). Results: Ninety patients were enrolled: 46 were randomised to standard care plus resuscitative endovascular balloon occlusion of the aorta and 44 to standard care. Mortality at 90 days was higher in the standard care plus resuscitative endovascular balloon occlusion of the aorta group (54%) compared to the standard care group (42%). The odds ratio was 1.58 (95% credible interval 0.72 to 3.52). The posterior probability of an odds ratio > 1 (indicating increased odds of death with resuscitative endovascular balloon occlusion of the aorta) was 86.9%. The overall effect did not change when an enthusiastic prior was used or when the estimate was adjusted for baseline characteristics. For the secondary outcomes (3, 6 and 24 hours mortality), the posterior probability that standard care plus resuscitative endovascular balloon occlusion of the aorta was harmful was higher than for the primary outcome. Additional analyses to account for intercurrent events did not change the direction of the estimate for mortality at any time point. Death due to haemorrhage was more common in the standard care plus resuscitative endovascular balloon occlusion of the aorta group than in the standard care group. There were no serious adverse device effects. Resuscitative endovascular balloon occlusion of the aorta is less costly (probability 99%), due to the competing mortality risk but also substantially less effective in terms of lifetime quality-adjusted life-years (probability 91%). Limitations: The size of the study reflects the relative infrequency of exsanguinating traumatic haemorrhage in the United Kingdom. There were some baseline imbalances between groups, but adjusted analyses had little effect on the estimates. Conclusions: This is the first randomised trial of the addition of resuscitative endovascular balloon occlusion of the aorta to standard care in the management of exsanguinating haemorrhage. All the analyses suggest that a strategy of standard care plus resuscitative endovascular balloon occlusion of the aorta is potentially harmful. Future work: The role (if any) of resuscitative endovascular balloon occlusion of the aorta in the pre-hospital setting remains unclear. Further research to clarify its potential (or not) may be required. Trial registration: This trial is registered as ISRCTN16184981. Funding: This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme (NIHR award ref: 14/199/09) and is published in full in

Indexed as

Balloon OcclusionCost-Benefit AnalysisEndovascular ProceduresResuscitationAdultAgedAortaBayes TheoremFemaleHemorrhageHumansMaleMiddle AgedQuality-Adjusted Life YearsTorsoTrauma CentersAORTIC BALLOON OCCLUSIONBAYESIAN ANALYSISHAEMORRHAGEHUMANRANDOMISED CONTROLLED TRIALREBOARESUSCITATIONTRAUMA

Identifiers

PMID39259521
PMCPMC11418015

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.